Search and apply for every grant in existence.

The U.S. Army Applications Laboratory (AAL) issued the Open Call Solicitation for Innovative AUS Solutions (W911NF-26-S-0040), a continuously open opportunity running from December 30, 2025 through August 31, 2026 to accelerate next-generation autonomous capabilities across air, ground, and maritime domains. The program is designed to attract both traditional defense contractors and non-traditional innovators delivering disruptive autonomy solutions. Focus areas include autonomous platforms (air, ground, maritime), payloads, mission-enabling software and hardware, lethal capabilities, sustainment solutions, subcomponents, and other disruptive autonomy innovations. The program uses a streamlined submission process requiring a 6-minute unclassified video pitch plus a structured submission form describing the solution, capabilities, and readiness. Monthly submission cutoffs occur at noon EST on the last day of each month. Submissions are assessed the following month with results within 30 days, and strong solutions deemed award-ready can move directly into contracting pathways without further competition. Award instruments include contracts and Other Transaction Agreements (OTAs) supporting R&D, prototyping, testing, production, fielding, and sustainment of autonomous and unmanned systems. Solutions are evaluated on technical merit, alignment with Army needs, team qualifications, problem definition clarity, and real-world applicability.

Manufacturing 4.0 is an adoption grant rather than a research grant, and that distinction governs everything about how it should be approached: Maryland Commerce is paying manufacturers to buy and install Industry 4.0 technology, not to invent it. Eligible expenses explicitly include artificial intelligence solutions for continuous improvement, robots and autonomous equipment to automate workflow, advanced sensor integration, embedded software system applications, industrial IoT, ERP and data analytics platforms, cybersecurity tools, additive manufacturing, systems integration, and the associated training and consulting fees - so an AI deployment paired with the integration work and staff training to make it stick is a natural fit. Grants range from USD 25,000 to USD 500,000 with a cost-share structure that materially favours the smallest firms: 75 percent of project costs are covered for manufacturers with 3 to 50 employees against 50 percent for those with 51 to 250, and 20 percent of programme funds are reserved for the small-manufacturer tier. Applicants must be existing Maryland manufacturers with a two-digit NAICS code of 31-33, between 3 and 250 full-time employees, at least two years of operating history, and good standing with state and federal occupational safety agencies. Note that robotics and equipment purchases must be new equipment. The FY2026 window is narrow - applications open 3 August 2026 at 9:00 AM and close 31 August 2026 at 5:00 PM - and awards are competitive and limited to available funds rather than guaranteed to all qualifying applicants.

The Merck Stimulating Innovative Research Grant Program 2026 includes a dedicated grant topic for artificial intelligence in cell culture media and process development, offering up to EUR 150,000 per year for up to 3 years. The program accelerates innovation through collaborative research, early engagement with industry experts, and translation of novel ideas into practical solutions. In 2026, priority areas also include in-vitro models for neuroinflammatory diseases (EUR 250,000/year for 2 years) and innovative approaches to contaminated materials remediation (EUR 150,000/year for 2 years). The two-stage application process begins with non-confidential submissions, followed by deep-dive workshops where finalists collaborate with Merck scientists and managers to jointly optimize proposals. The AI-specific grant focuses on applying machine learning and AI to optimize cell culture media formulation, bioprocess parameter optimization, and manufacturing quality control.